A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker
A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker
Recruiting · NCT06156527 · Registry updated 2023-12-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker | Lazertinib | Recruiting | Phase 2 | 2023-12-05 | NCT06156527 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Center, Korea | 52 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AJOU university hospital | Suwon | South Korea | 1 |
| Gangnam Severance Hospita | Seoul | South Korea | 1 |
| National Cancer Center | Goyang-si | South Korea | 1 |
| The Catholic University of Korea, St. Vincent's Hospital | Suwon | South Korea | 13 |
| Yonsei University Health System, Severance hospital | Seoul | South Korea | 13 |